Beta Bionics, Inc. Stock 12‑Month Price Target Raised to $20.23, Implies 33% Upside

• According to estimates from 11 analysts, Beta Bionics, Inc. stock's average price target has risen from $20 to $20.23, with forecasts ranging from $14 to $32 per share
• Based on the Jul. 29 closing price, the updated target implies approximately 33% potential upside
• Consensus rating remains at “Buy” across 11 covering analysts, with 8 Buys, 3 Holds and 0 Sells

Explore more price target data and ratings for Beta Bionics, Inc. on the , and track all previous and future analyst recommendations for Beta Bionics, Inc. in the dedicated .

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.